| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer | EVP Business Development
2 companies
Loerop James is a Chief Business Officer at Aclaris Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 2 sells.
Estimated insider holdings value: $822K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2023 | ACRS Aclaris Therapeutics, Inc. | Chief Business Officer | Buy | 14,705 | $6.80 | $99,958.71 | +210.6% | -86.8% | -82.0% | |
| Feb 8, 2023 | ACRS Aclaris Therapeutics, Inc. | Chief Business Officer | Sell | 4,267 | $13.89 | $59,272.47 | -37.9% | -39.7% | -91.4% | |
| Jul 9, 2020 | ANIK Anika Therapeutics, Inc. | EVP Business Development | Sell | 1,244 | $35.15 | $43,726.60 | -41.5% | - | - |